Fujimura T, Ohyashiki K, Ohyashiki J H, Kawakubo K, Iwabuchi A, Kodama A, Toyama K
First Department of Internal Medicine, Tokyo Medical College, Japan.
Cancer Genet Cytogenet. 1993 Jul 15;68(2):143-6. doi: 10.1016/0165-4608(93)90012-b.
We report two additional patients with acute myeloid leukemia (AML) and a translocation between chromosomes 7 and 11: t(7;11)(p15;p15). One patient was diagnosed as having AML-M2 and the other as AML with myelofibrosis. Both patients had low-level neutrophil alkaline phosphatase (NAP) scores. In the literature, only 15 AML patients with t(7;11)(p15;p15) have been reported; nine of them had an AML-M2 morphology, and all had a decreased NAP score. Moreover, mean survival of the reported AML patients with t(7;11)(p15;p15) was 15 months, although 85% of them obtained complete remission, indicating that this type of leukemia frequently tends to relapse. These findings indicate a strong association between the chromosome abnormality and hematologic manifestations of this disease.